Ionis Director Sells $413,588 in Stock as Company Nears 52-Week High
Lynne Parshall, a director at Ionis Pharmaceuticals (IONS), sold 5,000 shares on February 11, 2026, for $413,588 under a Rule 10b5-1 plan. The transaction occurred while the stock trades close to its 52-week high and follows several regulatory and clinical advances for the company that have attracted positive analyst attention.